Trial
NCT01965834
Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Miami
Collaborators
—
Condition
Multiple Myeloma
Intervention
Fenofibrate
Why stopped
Lack of adequate accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-06-14